The differences between the ‘software’ of humans and monkey brains have been disclosed by neuroscientists for the very first time using a technique that tracks single neurons. They found that brain...
Stopping breast cancer metastasis by killing tumor cells in their sleep Oncology researchers believed that dormant breast cancer cells are not responsive to chemotherapy. But these inactive cancer cells can be active at any time and cause life-threatening metastases. Scientists at the Fred Hutchinson Cancer Rese...
Find More
Ladies, January is the month of raising awareness about cervical cancer. In the US, 250000 women are affected every year. One can refrain from the cancer by avoiding human papillomavirus, or HPV, which is sexually transmitted. We can eliminate cervical cancer as a public health problem through intensified vaccinati...
Find More
Doctors now have a new weapon in the fight against cancer: detailed maps of the cells in a tumour that can be explored and analyzed in a virtual reality simulation that its creators say provides researchers with an intuitive new way to examine complex medical data that could lead to unexpected breakthroughs. Bui...
Find More
Anti-aging startup Juvenescence raises USD 46 Million Juvenescence has bagged the USD 46 million in series B financing. The investment tees the anti-ageing startup to progress the multi-asset pipeline. Jim Mellon, a British billionaire biotech investor, created Juvenescence with early Medivation backer Greg Bai...
Find More
A survey was done in which thousands of advanced cancers indicated a way to detect those that respond to revolutionary therapies that unleash an immune response against tumours. However, the results show difficulty level to translate an approach into a reliable clinical test. The findings are the latest evidence to...
Find More
Abbott’s pea-sized implant for congenital heart defects gets FDA approval FDA approved Abbott for its Amplatzer Piccolo Occluder, the implant designed for premature babies. The device is used to treat patent ductus arteriosus (PDA), a life-threatening opening in the hearts of premature newborns and is a minimal...
Find More
Breast cancer develops when breast tissue cells grow abnormally and multiply. In essence, the hormones-- estrogen and progesterone-- and excess levels of human epidermal growth factor receptor 2 (HER2) protein are the known drivers of breast cancer. By testing samples of breast cancer tissue for hormone receptors a...
Find More
Apollomics raises USD 100 Million for funding of transpacific cancer R&D plan Apollomics has raised USD 100 million for funding an oncology clinical trial program. The series B round sets Apollomics to progress its c-Met inhibitor and pipeline of other clinical-phase assets. OrbiMed Asia-backed Apo...
Find More
A range of rare genetic disorders is pinpointed by a deep-learning algorithm. This helps doctors and researchers by analysing pictures of people’s faces. Researchers describe the technology after the diagnostic aid, a smartphone app called Face2Gene. It relies on machine-learning algorithmsand brain-like neural...
Find More
A rare neurological disorder characterized by progressive weakness and impaired sensory function in .....
Find More
Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....
Find More
Metachromatic Leukodystrophy (MLD) is a rare hereditary disease characterized by the accumulation of.....
Find More
Chronic Pancreatitis is an inflammation of the pancreas that can be a result of calcium stones and c.....
Find More
Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of Pulmonary Hyperten.....
Find More
The Digital Era has officially hit Prime Time. Currently, the potentiality to digitally transform a .....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
